Review Article - Pharmacological management of diabetic retinopathy: Current trends and emerging therapies
Journal of Kenya Assocation of Physicians · 08.04.2026 · 8 (1) · 4-12
DOI: 10.4314/jkap.v8i1.2 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Kenya Assocation of Physicians, online erschienen am 08.04.2026. Verfasst von Maduabuchukwu Innocent Nkollo. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Background
Diabetic Retinopathy (DR) is a leading cause of preventable vision loss worldwide. Over the past decade, pharmacological therapies have revolutionized management, shifting emphasis from laser photocoagulation to intravitreal agents.
Objective
This review summarizes current pharmacological treatments, evaluates evidence from pivotal clinical trials, and discusses emerging therapeutic strategies in DR management.
Methods
A narrative synthesis of recent guidelines, clinical trial data, and regulatory updates was undertaken, emphasizing anti-VEGF therapy, dual-pathway inhibition, corticosteroid implants, systemic agents, and emerging therapies.
Results
Anti-VEGF therapy remains the gold standard for Diabetic Macular Edema (DME) and Proliferative DR (PDR), with aflibercept 8mg (Eylea HD) and faricimab (vabysmo) offering improved durability. Corticosteroid implants provide alternatives in refractory or pseudophakic cases. Panretinal photocoagulation remains relevant where adherence is uncertain. Systemic agents, notably fenofibrate, reduce DR progression. Emerging therapies include sustained-delivery systems, gene therapy, integrin inhibitors, and Artificial Intelligence (AI)-assisted screening.
Conclusion
Pharmacological management of DR is in a transition toward extended-dosing, dualmechanism inhibition, and systemic adjunctive therapies. Integration of AI-enabled screening and next-generation therapeutics promises to reduce treatment burden and improve visual outcome.
Zitieren
APA
Nkollo, M. I. (2026). Review Article - Pharmacological management of diabetic retinopathy: Current trends and emerging therapies. Journal of Kenya Assocation of Physicians, 8(1), 4-12. https://doi.org/10.4314/jkap.v8i1.2
Vancouver
Nkollo MI. Review Article - Pharmacological management of diabetic retinopathy: Current trends and emerging therapies. Journal of Kenya Assocation of Physicians. 2026;8(1):4-12. doi:10.4314/jkap.v8i1.2
BibTeX
@article{Nkollo2026,
author = {Nkollo, Maduabuchukwu Innocent},
title = {Review Article - Pharmacological management of diabetic retinopathy: Current trends and emerging therapies},
journal = {Journal of Kenya Assocation of Physicians},
year = {2026},
volume = {8},
number = {1},
pages = {4--12},
doi = {10.4314/jkap.v8i1.2}
}
EUVIMED